SCHEMBL466548

SCHEMBL466548

C=C(C)CCCCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL466592 1.00 GPR84 (0.43)
SCHEMBL466721 1.00 GPR84 (0.43)
SCHEMBL466959 1.00 GPR84 (0.43)
SCHEMBL466671 1.00 GPR84 (0.43)
SCHEMBL466782 0.97
SCHEMBL466793 0.88
SCHEMBL27605472 0.87 TDP1 (0.41)
SCHEMBL8466765 0.87 TDP1 (0.41)
SCHEMBL25978438 0.87 TDP1 (0.41)
SCHEMBL4797472 0.87 TDP1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107337765-B Phosphonic acid-based polymer with strong adaptability and slump retaining performance as well as preparation method and application thereof 江苏苏博特新材料股份有限公司 2020-10-23 CN claimed
EP-4593859-A1 COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION Eresina, LLC (US) 2025-08-06 EP disclosed
WO-2024073011-A1 TOPICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION ERESINA, LLC (US) 2024-04-04 WO disclosed
WO-2024073013-A1 COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION ERESINA, LLC (US) 2024-04-04 WO disclosed
US-10815212-B2 Cytotoxin compounds and methods of isolation UNIVERSITY OF SOUTH FLORIDA (US) 2020-10-27 US disclosed
CN-107337765-B Phosphonic acid-based polymer with strong adaptability and slump retaining performance as well as preparation method and application thereof 江苏苏博特新材料股份有限公司 2020-10-23 CN disclosed
US-20160297790-A1 CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION UNIV SOUTH FLORIDA (US) 2016-10-13 US disclosed
US-9394270-B2 Cytotoxin compounds and methods of isolation UNIVERSITY OF SOUTH FLORIDA (US) 2016-07-19 US disclosed
US-8877857-B2 Polar group-containing copolymer, rubber composition and studless tire SUMITOMO RUBBER INDUSTRIES, LTD. (JP) 2014-11-04 US disclosed
US-20140194495-A1 CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION THE UAB RESEARCH FOUNDATION (US) 2014-07-10 US disclosed
EP-2404944-B1 POLAR GROUP-CONTAINING COPOLYMER, RUBBER COMPOSITION AND STUDLESS TIRE SUMITOMO RUBBER IND (JP) 2014-05-14 EP disclosed
US-8669376-B2 Cytotoxin compounds and methods of isolation UNIVERSITY OF SOUTH FLORIDA (US) 2014-03-11 US disclosed
WO-2012135669-A1 NITROGEN RING CONTAINING COMPOUNDS FOR TREATMENT OF INFLAMMATORY DISORDERS WEINGARTEN M DAVID (US) 2012-10-04 WO disclosed
US-20120095153-A1 POLAR GROUP-CONTAINING COPOLYMER, RUBBER COMPOSITION AND STUDLESS TIRE SUMITOMO RUBBER INDUSTRIES, LTD. (JP) 2012-04-19 US disclosed
EP-2404944-A1 POLAR GROUP-CONTAINING COPOLYMER, RUBBER COMPOSITION AND STUDLESS TIRE Sumitomo Rubber Industries, Ltd. (JP) 2012-01-11 EP disclosed
US-20090192215-A1 Cytotoxin Compounds and Methods of Isolation UNIVERSITY OF SOUTH FLORIDA (US) 2009-07-30 US disclosed
EP-1934196-A2 CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION University of South Florida (US) 2008-06-25 EP disclosed
WO-2007035734-A2 CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION UNIVERSITY OF SOUTH FLORIDA (US) 2007-03-29 WO disclosed